TAO Synergies Inc.
NASDAQ: TAOX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joshua N. Silverman
- Employees
- 4
- Headquarters
- New York, United States
- IPO year
- 2025
- Market cap
- $11.1M
- Website
- https://www.synaptogen.com
Loading TAOX…
Loading profile data…Frequently asked questions about TAOX
What does TAO Synergies Inc. (TAOX) do?
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its t...
Where does TAOX trade?
TAO Synergies Inc. (TAOX) trades on the NASDAQ Global Market.
What sector is TAOX in?
TAO Synergies Inc. (TAOX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TAO Synergies Inc.?
Joshua N. Silverman is the chief executive officer of TAO Synergies Inc. (TAOX).
Where is TAO Synergies Inc. headquartered?
TAO Synergies Inc. is headquartered in United States.
Does TAOX pay a dividend?
TAO Synergies Inc. (TAOX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TAOX go public?
TAO Synergies Inc. (TAOX) completed its initial public offering in 2025.